Adrenaline‐induced hypotension in the context of significant quetiapine overdose

In patients presenting with hypotension due to significant quetiapine or mixed overdose, adrenaline should be avoided and consider medications such as noradrenaline or vasopressin as an alternative. If using noradrenaline peripherally, use a lower concentration (4 mg in 50 mL 5% glucose) and use a l...

Descripción completa

Detalles Bibliográficos
Autores principales: Anomelechi, Enyioma, Hirst, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017399/
https://www.ncbi.nlm.nih.gov/pubmed/36937626
http://dx.doi.org/10.1002/ccr3.7117
_version_ 1784907574159605760
author Anomelechi, Enyioma
Hirst, Robert
author_facet Anomelechi, Enyioma
Hirst, Robert
author_sort Anomelechi, Enyioma
collection PubMed
description In patients presenting with hypotension due to significant quetiapine or mixed overdose, adrenaline should be avoided and consider medications such as noradrenaline or vasopressin as an alternative. If using noradrenaline peripherally, use a lower concentration (4 mg in 50 mL 5% glucose) and use a large bore cannula in a large vein.
format Online
Article
Text
id pubmed-10017399
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100173992023-03-17 Adrenaline‐induced hypotension in the context of significant quetiapine overdose Anomelechi, Enyioma Hirst, Robert Clin Case Rep Case Report In patients presenting with hypotension due to significant quetiapine or mixed overdose, adrenaline should be avoided and consider medications such as noradrenaline or vasopressin as an alternative. If using noradrenaline peripherally, use a lower concentration (4 mg in 50 mL 5% glucose) and use a large bore cannula in a large vein. John Wiley and Sons Inc. 2023-03-15 /pmc/articles/PMC10017399/ /pubmed/36937626 http://dx.doi.org/10.1002/ccr3.7117 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Anomelechi, Enyioma
Hirst, Robert
Adrenaline‐induced hypotension in the context of significant quetiapine overdose
title Adrenaline‐induced hypotension in the context of significant quetiapine overdose
title_full Adrenaline‐induced hypotension in the context of significant quetiapine overdose
title_fullStr Adrenaline‐induced hypotension in the context of significant quetiapine overdose
title_full_unstemmed Adrenaline‐induced hypotension in the context of significant quetiapine overdose
title_short Adrenaline‐induced hypotension in the context of significant quetiapine overdose
title_sort adrenaline‐induced hypotension in the context of significant quetiapine overdose
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017399/
https://www.ncbi.nlm.nih.gov/pubmed/36937626
http://dx.doi.org/10.1002/ccr3.7117
work_keys_str_mv AT anomelechienyioma adrenalineinducedhypotensioninthecontextofsignificantquetiapineoverdose
AT hirstrobert adrenalineinducedhypotensioninthecontextofsignificantquetiapineoverdose

Ejemplares similares